126 related articles for article (PubMed ID: 10978383)
1. Calcineurin-inhibitors in renal transplantation. Too precious to be abandoned.
Ponticelli C
Nephrol Dial Transplant; 2000 Sep; 15(9):1307-9. PubMed ID: 10978383
[No Abstract] [Full Text] [Related]
2. Which calcineurin inhibitor is preferred in renal transplantation: tacrolimus or cyclosporine?
Vanrenterghem YF
Curr Opin Nephrol Hypertens; 1999 Nov; 8(6):669-74. PubMed ID: 10630811
[TBL] [Abstract][Full Text] [Related]
3. Rapamycin use and rapid withdrawal of calcineurin inhibitors in pediatric renal transplantation.
Vilalta R; Vila A; Nieto J; Callís L
Transplant Proc; 2003 Mar; 35(2):703-4. PubMed ID: 12644102
[No Abstract] [Full Text] [Related]
4. Calcineurin inhibitors in pediatric renal transplant recipients.
Filler G
Paediatr Drugs; 2007; 9(3):165-74. PubMed ID: 17523697
[TBL] [Abstract][Full Text] [Related]
5. Effect of low-dose calcineurin inhibitors on acute rejection and graft survival.
Altaca G; Berber I; Aydin C; Titiz I
Transplant Proc; 2002 Sep; 34(6):2079-80. PubMed ID: 12270320
[No Abstract] [Full Text] [Related]
6. Calcineurin inhibitors in renal transplantation: what is the best option?
Tanabe K
Drugs; 2003; 63(15):1535-48. PubMed ID: 12887261
[TBL] [Abstract][Full Text] [Related]
7. Point: A call for advanced pharmacokinetic and pharmacodynamic monitoring to guide calcineurin inhibitor dosing in renal transplant recipients.
van Rossum HH; Press RR; den Hartigh J; de Fijter JW
Clin Chem; 2010 May; 56(5):732-5. PubMed ID: 20207765
[No Abstract] [Full Text] [Related]
8. Tacrolimus as cornerstone immunosuppressant in kidney transplantation.
Berloco P; Rossi M; Pretagostini R; Sociu-Foca Cortesini N; Cortesini R
Transplant Proc; 2001; 33(1-2):994-6. PubMed ID: 11267161
[No Abstract] [Full Text] [Related]
9. Counterpoint: Is pharmacokinetic or pharmacodynamic monitoring of calcineurin inhibition therapy necessary?
Marquet P
Clin Chem; 2010 May; 56(5):736-9. PubMed ID: 20224048
[No Abstract] [Full Text] [Related]
10. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
Nashan B
Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616
[TBL] [Abstract][Full Text] [Related]
11. Optimization of the use of Calcineurin inhibitors in liver transplantation.
de Mare-Bredemeijer EL; Metselaar HJ
Best Pract Res Clin Gastroenterol; 2012 Feb; 26(1):85-95. PubMed ID: 22482528
[TBL] [Abstract][Full Text] [Related]
12. How should the immunosuppressive regimen be managed in patients with established chronic allograft failure?
Danovitch GM
Kidney Int Suppl; 2002 May; (80):68-72. PubMed ID: 11982816
[No Abstract] [Full Text] [Related]
13. Authors' reply: cyclosporine A versus tacrolimus in steroid withdrawal strategies.
Pascual J; Royuela A; Zamora J
Transplantation; 2011 Mar; 91(5):e26. PubMed ID: 21336083
[No Abstract] [Full Text] [Related]
14. Calcineurin inhibitor sparing immunosuppressive regimens in kidney allograft recipients.
Baczkowska T; Durlik M
Pol Arch Med Wewn; 2009 May; 119(5):318-25. PubMed ID: 19579814
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of the cellular pharmacodynamics of calcineurin inhibitors between patients with chronic renal failure awaiting renal transplantation and cirrhosis patients awaiting liver transplantation.
Kihara Y; Matsuno N; Mijiti A; Nagao T; Takeuchi H; Unezaki S; Hirano T
Cell Transplant; 2009; 18(5):639-46. PubMed ID: 19775526
[TBL] [Abstract][Full Text] [Related]
16. Histopathological findings according to Banff-97 classification system comparing tacrolimus versus cyclosporine.
Rodrigo E; Escallada R; Fernández-Fresnedo G; Ruiz JC; Piñera C; Herráez I; Cotorruelo JG; Zubimendi JA; de Francisco AL; Arias M
Transplant Proc; 2002 Aug; 34(5):1719-20. PubMed ID: 12176550
[No Abstract] [Full Text] [Related]
17. [Interaction between sildenafil and calcineurin inhibitors in renal transplant recipients with erectile dysfunction].
Cofán F; Gutiérrez R; Beardo P; Campistol JM; Oppenheimer F; Alcover J
Nefrologia; 2002; 22(5):470-6. PubMed ID: 12497749
[TBL] [Abstract][Full Text] [Related]
18. Balancing efficacy and toxicity in kidney-transplant immunosuppression.
Leichtman AB
N Engl J Med; 2007 Dec; 357(25):2625-7. PubMed ID: 18094383
[No Abstract] [Full Text] [Related]
19. Immune monitoring with a lymphocyte adenosine triphosphate assay in kidney transplant recipients treated with a calcineurin inhibitor.
Sugiyama K; Tsukaguchi M; Toyama A; Satoh H; Saito K; Nakagawa Y; Takahashi K; Tanaka S; Onda K; Hirano T
Exp Clin Transplant; 2014 Jun; 12(3):195-9. PubMed ID: 24907718
[TBL] [Abstract][Full Text] [Related]
20. Induction of the unfolded protein response by calcineurin inhibitors: a double-edged sword in renal transplantation.
Kitamura M
Nephrol Dial Transplant; 2010 Jan; 25(1):6-9. PubMed ID: 19797334
[No Abstract] [Full Text] [Related]
[Next] [New Search]
